Sudhir Kumar Singh

Sudhir Kumar Singh serves as the Chief Executive Officer of Suven Pharmaceuticals Ltd since September 2023 and previously held the role of Executive Vice President at GVK Biosciences, overseeing overall strategy, operations, and business growth from February 2013 to the present. Singh also contributed to Advent International as a Consultant from May 2023 to September 2023 and was the Chief Operating Officer at Aragen Life Sciences from February 2019 to April 2023. Prior executive experience includes positions at Jubilant Chemsys Ltd, Aurigene Discovery Technologies, and significant academic roles as a Research Assistant Professor at Rutgers University and a Post Doctoral Fellow at Thomas Jefferson University. Singh holds a Ph.D. in Medicinal Chemistry from the Central Drug Research Institute and additional postdoctoral fellowships from the University of Alabama at Birmingham and Buffalo State University.